These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 16928223)

  • 41. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
    Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
    Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of HSP27 in colorectal carcinoma and its relationship with lymphatic metastasis].
    Zhao L; Li ZG; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):41-4. PubMed ID: 18227023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
    Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
    World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expression and location of midkine in gastric carcinomas of Chinese patients.
    Huang Y; Cao G; Wang H; Wang Q; Hou Y
    Cell Mol Immunol; 2007 Apr; 4(2):135-40. PubMed ID: 17484808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of loss of Fhl1 expression in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Ann Surg Oncol; 2008 Aug; 15(8):2293-300. PubMed ID: 18465173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.
    Ye Q; Zheng MH; Cai Q; Feng B; Chen XH; Yu BQ; Gao YB; Ji J; Lu AG; Li JW; Wang ML; Liu BY
    Cancer Sci; 2008 Oct; 99(10):1924-32. PubMed ID: 19016751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
    Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
    Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.